Green Cross Pharmaceuticals,·Venture Capital, Invest $12 million in AI Healthcare
- 2018. 11. 26
VUNO has received $12 million in Series B funding. In this round, 4 venture capital funds and Korea's largest
pharmaceutical company participated.
Previous investor Smilegate Investments, SBI investments, HB Investments, Future Play participated in this round.
Green Cross Pharmaceuticals participated as a new strategic investor. Collectively, the investors participated
in a round of $12 million dollars in a redeemable convertible preference shares (RCPS) format.